Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer
This is a single center study to assess the efficacy of CyPath® Early Detection Lung Cancer Assay to detect lung cancer cells from deep lung sputum.
Checked against the public recordLast updated Jul 14, 2015 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Diagnostic
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- bioAffinity Technologies Inc.
- Interventions being studied
- Device: CyPath®
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Participants who have never smoked nor have known lung diseases Exclusion Criteria: * Severe obstructive lung disease * Angina with minimal exertion * Pregnancy * Have or have had cancer other than lung cancer * Worked in the mining Industry
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Radiology Associates of Albuquerque (RAA)Albuquerque, New Mexico
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 14, 2015. Always confirm current availability with the study team.